CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear
Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for older leukemia patients: targeted pill shows promise
Disease control OngoingThis phase II study tests a daily pill called PCI-32765 (ibrutinib) in 86 people with chronic lymphocytic leukemia or small lymphocytic lymphoma who are over 65 or have a specific genetic change (17p deletion). These groups often do not respond well to standard chemotherapy. Part…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC